Safe Orthopaedics announces CE mark for new Hickory screw
TMPS next-generation range
Launch of a study in Germany with Dr. Jens A.Richolt
Worldwide commercialisation expected in 2022
Éragny-sur-Oise, France, May 27
th, 2021 at 8:55 a.m. CET – Safe Orthopaedics (FR0013467123 – ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announced today that it has obtained CE Mark approval for Hickory, a new treatment for the management of osteoporotic patients.
Osteoporosis is a global clinical issue. This disease, which affects a growing number of people, mainly affects those over 50 years of age and has consequences for the treatment of spinal pathologies. Safe Orthopaedics, which recently announced the launch of Sycamore for the treatment of vertebral fractures, is now offering Hickory for the treatment of other pathologies requiring pe
Safe Orthopaedics announces CE mark for new Hickory screw
TMPS next-generation range
Launch of a study in Germany with Dr. Jens A.Richolt
Worldwide commercialisation expected in 2022
Éragny-sur-Oise, France, May 27
th, 2021 at 8:55 a.m. CET - Safe Orthopaedics (FR0013467123 - ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announced today that it has obtained CE Mark approval for Hickory, a new treatment for the management of osteoporotic patients.
Osteoporosis is a global clinical issue. This disease, which affects a growing number of people, mainly affects those over 50 years of age and has consequences for the treatment of spinal pathologies. Safe Orthopaedics, which recently announced the launch of Sycamore for the treatment of vertebral fractures, is now offering Hickory for the treatment of other pathologies requiring pedicle scre